Tomohiko Kamimura

1.6k total citations
64 papers, 871 citations indexed

About

Tomohiko Kamimura is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Tomohiko Kamimura has authored 64 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 23 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Tomohiko Kamimura's work include Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (15 papers) and Acute Myeloid Leukemia Research (11 papers). Tomohiko Kamimura is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (15 papers) and Acute Myeloid Leukemia Research (11 papers). Tomohiko Kamimura collaborates with scholars based in Japan and United States. Tomohiko Kamimura's co-authors include Yoshikiyo Ito, Yong Chong, Toshihiro Miyamoto, Koichi Akashi, Tetsuya Eto, Mine Harada, Takanori Teshima, Shinji Shimoda, Koji Nagafuji and Nobuyuki Shimono and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Tomohiko Kamimura

59 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiko Kamimura Japan 19 359 279 195 178 170 64 871
Montserrat Arnán Spain 19 242 0.7× 469 1.7× 216 1.1× 537 3.0× 167 1.0× 53 1.3k
Noam Benyamini Israel 17 310 0.9× 451 1.6× 124 0.6× 144 0.8× 99 0.6× 53 963
Isabel Sánchez‐Ortega Spain 17 374 1.0× 454 1.6× 108 0.6× 404 2.3× 79 0.5× 50 1.1k
Mario Delia Italy 16 189 0.5× 271 1.0× 83 0.4× 246 1.4× 78 0.5× 48 824
Yoshikiyo Ito Japan 15 154 0.4× 177 0.6× 195 1.0× 144 0.8× 76 0.4× 41 571
E. Kurrle Germany 18 240 0.7× 335 1.2× 91 0.5× 166 0.9× 99 0.6× 68 826
Misato Kikuchi Japan 15 359 1.0× 270 1.0× 19 0.1× 209 1.2× 102 0.6× 64 743
Morena Caira Italy 21 96 0.3× 515 1.8× 229 1.2× 590 3.3× 100 0.6× 49 1.3k
Ola Blennow Sweden 13 127 0.4× 268 1.0× 30 0.2× 252 1.4× 53 0.3× 26 628
A Domingo-Albós Spain 17 296 0.8× 177 0.6× 22 0.1× 190 1.1× 52 0.3× 37 702

Countries citing papers authored by Tomohiko Kamimura

Since Specialization
Citations

This map shows the geographic impact of Tomohiko Kamimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiko Kamimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiko Kamimura more than expected).

Fields of papers citing papers by Tomohiko Kamimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiko Kamimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiko Kamimura. The network helps show where Tomohiko Kamimura may publish in the future.

Co-authorship network of co-authors of Tomohiko Kamimura

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiko Kamimura. A scholar is included among the top collaborators of Tomohiko Kamimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiko Kamimura. Tomohiko Kamimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Yasuo, Jun Takizawa, Naoki Takezako, et al.. (2024). Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma. Cancer Science. 115(6). 2002–2011. 1 indexed citations
2.
Sugio, Takeshi, Naoyuki Uchida, Kohta Miyawaki, et al.. (2024). Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation. Bone Marrow Transplantation. 59(4). 466–472.
3.
Kikushige, Yoshikane, Yuichiro Semba, Takahiro Shima, et al.. (2024). TIM‐3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation. Cancer Science. 116(3). 698–709.
4.
Fuji, Shigeo, Junichi Sugita, Yuho Najima, et al.. (2023). Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British Journal of Haematology. 204(3). 959–966. 6 indexed citations
5.
Miyamoto, Toshihiro, Tetsuya Eto, Naoyuki Uchida, et al.. (2021). Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008. International Journal of Hematology. 113(6). 815–822. 2 indexed citations
6.
Sugita, Junichi, Tomohiko Kamimura, Takayuki Ishikawa, et al.. (2020). Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation. Bone Marrow Transplantation. 56(3). 596–604. 33 indexed citations
7.
Nagafuji, Koji, Toshihiro Miyamoto, Tetsuya Eto, et al.. (2019). Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia. European Journal Of Haematology. 103(3). 164–171. 8 indexed citations
8.
Yanada, Masamitsu, Akiyoshi Takami, Shohei Mizuno, et al.. (2019). Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan. International Journal of Hematology. 111(1). 93–102. 14 indexed citations
9.
Aoki, Takatoshi, Tomohiko Kamimura, Shuro Yoshida, et al.. (2019). Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1576–1585. 10 indexed citations
10.
Ishikawa, Jun, Itaru Matsumura, Tatsuya Kawaguchi, et al.. (2018). Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial). International Journal of Hematology. 107(5). 535–540. 5 indexed citations
11.
Takami, Akiyoshi, Masahiko Hara, Shohei Mizuno, et al.. (2017). Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 23(9). 1447–1454. 20 indexed citations
12.
13.
Chong, Yong, Shinji Shimoda, Yoshikiyo Ito, et al.. (2013). Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity. PLoS ONE. 8(1). e54190–e54190. 27 indexed citations
14.
Kamimura, Tomohiko, et al.. (2013). High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib. International Journal of Hematology. 98(6). 694–701. 3 indexed citations
15.
Takenaka, Katsuto, Koji Nagafuji, Ken Takase, et al.. (2012). Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. International Journal of Hematology. 96(1). 94–100. 7 indexed citations
16.
Ito, Yoshikiyo, et al.. (2012). Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulin. International Journal of Hematology. 97(1). 135–138. 28 indexed citations
17.
Kamimura, Tomohiko, Yong Chong, & Yoshikiyo Ito. (2011). Continuous intravenous infusion of fentanyl for pain due to stomatitis, pharyngitis, and esophagitis after hematopoietic stem cell transplantation. Palliative Care Research. 6(2). 246–252. 1 indexed citations
18.
Takeishi, Shoichiro, Toshihiro Miyamoto, Atsushi Nonami, et al.. (2007). Toxoplasmosis encephalitis following severe graft‐vs.‐host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. European Journal Of Haematology. 79(4). 317–321. 32 indexed citations
19.
Takamatsu, Yasushi, Kentaro Ogata, Keita Yamauchi, et al.. (2005). An Evaluation of Busulfan Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation. Japanese Journal of Clinical Oncology. 35(7). 400–403. 8 indexed citations
20.
Miyamoto, Toshihiro, Takashi Okamura, Tetsuya Eto, et al.. (1998). Effect of thrombopoietin on proliferation of blasts from CD7‐positive acute myelogenous leukaemia. British Journal of Haematology. 102(5). 1232–1240. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Montserrat Arnán Breakdown of academic impact, for papers by Noam Benyamini Breakdown of academic impact, for papers by Isabel Sánchez‐Ortega Breakdown of academic impact, for papers by Mario Delia Breakdown of academic impact, for papers by Yoshikiyo Ito Breakdown of academic impact, for papers by E. Kurrle Breakdown of academic impact, for papers by Misato Kikuchi Breakdown of academic impact, for papers by Morena Caira Breakdown of academic impact, for papers by Ola Blennow Breakdown of academic impact, for papers by A Domingo-Albós
Rankless by CCL
2026